Results 211 to 220 of about 8,467,334 (349)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Community Health Nurses' Knowledge and Perceptions of AI in Canada: National Cross-Sectional Survey. [PDF]
Henderson Betkus M +4 more
europepmc +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Health, Socioeconomic Status, and Opioid Use Disorder: Risk Factors Among Individuals With Nonmedical Opioid Use. [PDF]
Park K, Yang TC.
europepmc +1 more source
DIGITAL CRISIS COMMUNICATION CASE STUDIES FROM HEALTH EMERGENCIES (SDG 3 GOOD HEALTH & WELL-BEING)
Dennis B. Brosola +2 more
openalex +2 more sources
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Self-reported health status and associated factors among community-dwelling Afro-Caribbean Black Canadians: a cross-sectional comparison before and during the pandemic. [PDF]
Koné AP +12 more
europepmc +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source

